Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Randeva, Harpal S.
Text and Data Mining valid from 2020-07-15
Version of Record valid from 2020-07-15
26 May 2020
2 July 2020
15 July 2020
Ethics approval and consent to participate
The authors declare that they have no competing interests.